The Viability of Cancerous vs. Non-cancerous Cells by Nickels, Logan
Lung cancer is a disease that 
affects a number of human beings 
in the world each and every day. It is 
the number one cancer-related cause 
of death in men, and the number 
two cancer-related cause of death in 
women. It also has a high mortality 
rate when compared to other cancers. 
These factors, combined with the 
high-profile nature of cancer make it 
imperative that we study this disease 
and find ways to defeat it. My research 
with the University of Kansas’ High 
Throughput Screening laboratory is 
the beginning of finding ways to defeat 
this disease. Every drug on the market 
has some mode of action. A compound 
will bind to a receptor, or block the 
synthesis of another compound, or act 
in some way that affects the cell. Here, 
we are looking for the differences that 
cancerous and non-cancerous cells 
have. With this research, we can find 
compounds that inhibit the growth 
of cancerous cells, and do not inhibit 
the growth of non-cancerous cells, 
and then find common modes of 
action for those compounds. If there 
is a common mode throughout many 
different compounds, then that mode 
of action can be isolated and further 
researched for drug delivery. 
In my specific work, we used 
two different lung cell types: the 
MRC-5 cell line, which is a normal 
lung fibroblast, and the A-549, which 
is a cancerous lung cell. These were 
not identical cell lines, as they did not 
originate from the same human being, 
but they were close matches. The way 
we decided to approach the problem is 
to use a cell-based assay to inject the 
compounds into the cells, and then 
measure the cells’ growth. To find 
the effects the compounds had on the 
cells, we needed some way to visualize 
the viability of the cell lines. To do this, 
we used the reagent Cell Titer-Glo. 
This reagent reacts with the amount 
of ATP present, and luminesces at 
different intensities corresponding to 
the amount of ATP. Therefore, if many 
cells were to survive, the luminescence 
value would be very high and, 
contrastingly, if the cells were to 
die, then the values would be lower. 
However, before this reagent could be 
used, preliminary experiments had to 
be performed. 
The first experiment to be 
performed was to obtain growth curves 
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for both cell lines. This would allow us 
to not only find the optimal seeding 
density for both lines, but to also 
associate specific luminescence values 
with specific numbers of cells. This 
was done by using a hemocytometer to 
place a specific number of cells within 
a well of a standard 384-well plate, 
and using the Cell Titer-Glo reagent 
combined with the Tecan Safire, 2 a 
device that measures luminescence 
values, a luminescence value for that 
number of cells could be obtained. 
When that was done, the cells were 
then plated at specific densities, and 
allowed to grow. The plates were 
read with the Cell Titer-Glo reagent 
every 24 hours, and the luminescence 
values noted. Since the luminescence 
values could only be obtained using 
black plates, a separate set of cells 
were plated in clear plates, and using 
a photographic microscope, a good 
visual representation of the different 
densities could be obtained as well. 
The plates with the higher seeding 
densities began to show cell death 
after 48 hours, and the lower seeding 
densities continued to grow. After 
the full 4 days of growth, the results 
showed that the optimal seeding 
density for both the MRC-5 cell line 
and the A-549 cell line was 1,500 cells 
per well. This would allow the cells to 
grow to full confluency over the four 
days of the project, but not experience 
cell death due to overconfluency. If the 
cells are overly confluent, then they 
Figure 1. This is the growth curve of the non-cancerous MRC-5 cell line, with an ideal plating 
density of 1,500 cells / well of a 384-well plate.
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begin to stack on top of each other, 
use all of their nutrients, and die in 
their own waste. This would skew the 
results of the final project, so it was 
imperative that we find the proper 
seeding density.
The second experiment to be 
performed before the actual assay 
was a toxicity screen. The compounds 
used in the screen were stored in 
384-well polypropylene plates. The 
plates contained 20 µl of compound 
Figure 2. This graph shows the growth curve of the cancerous A-549 cells, which have an ideal 
plating density of 1,500 cells / well of a 384-well plate.
FIgure 3. Day 1 of the highest seeding 
density, 16,000 cells / well of the MRC-5 line
FIgure 4. Day 4 of the A-549 1,000 cells / well 
density,	nearing	confluency
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in each well, frozen in 2.25% DMSO 
in water. Since DMSO is toxic to cells, 
this test was required to ensure that 
addition of compound would only 
induce toxicity due to the effects of 
compound, not DMSO. By adding 
different concentrations of DMSO 
to cell lines, the cell viability was 
observed by using Cell Titer-Glo and 
the Tecan Safire2, as in the growth 
curve experiment. By comparing the 
luminescence values obtained with 
the DMSO lines to the growth curve, 
cell viability was easily established. 
Since after compound addition, the 
cells would be in approximately 
0.65% DMSO, as long as the cell lines 
were viable in that concentration of 
DMSO, then the screen could proceed 
as planned.
To accomplish this, two black 
plates were seeded with 1,500 cells per 
well, one plate of each cell type. This 
seeding density was found previously 
in the growth curve experiment. These 
plates were allowed to grow for two 
days, and then, as per the protocol for 
the final assay, a mock compound was 
added, using the BioMek FX robotic 
system. This mock compound was 
simply a salt solution with different 
concentrations across the board. After 
addition, the concentrations of DMSO 
ranged from 0.0%, all the way to 
4.0%. This would allow for reliability 
of results, and a great range of DMSO 
toxicity results. After the addition of 
the mock compound, the cells were 
grown another two days, and then 
read using Cell Titer-Glo and the Tecan 
Safire2. The results showed that for 
both cell lines, the DMSO concentration 
used in the final assay was well within 
safe levels, and that the non-cancerous 
line did not show signs of toxicity until 
a concentration of 2%. The cancerous 
line, however, seemed to be more 
hardy than the non-cancerous line, 
not showing signs of toxicity until a 
concentration of nearly 4%.
Figure 5. This graph plots the number of compounds vs. their percentages away from 
normalized values. Overall, there were 79 compounds that were at least 50% below the 
normalized value, and 103 compounds at least 50% above the normalized value, for a total 
of	182	compounds	classified	as	“active.”	Of	the	103	active	compounds	above	50%	of	the	
normalized value, 69 of them were of suspiciously high values, and in a concentrated area of 
one plate, possibly indicating a liquid handling error.
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After these experiments were 
performed, the final cell assay could 
continue. The optimal cell densities 
had been set, luminescence values 
could be traced back to actual cell 
numbers, and the DMSO concentration 
being used in the final assay was 
not toxic. The cells were plated at 
their optimal densities in black 384-
well plates, and then grown for two 
days before compound addition. The 
compounds used came from different 
libraries, compiled by different 
laboratories. The libraries used in the 
screen were the Prestwick (Prestwick 
Chemical, Illkirch, France) and the 
Spectrum Collection (Microsource 
Discovery Systems, Inc., Gaylordsville, 
CT) libraries, which contain a very 
small fraction of the total compounds 
available to the KU HTS lab. The reason 
for the small selection of compounds 
was, again, a time limitation associated 
with the constraints of an independent 
study.  These libraries consist of small 
molecules with known biological 
activity.  The purpose of these libraries 
is to see how compounds with a 
variety of biological activities behave 
in an assay.  Thus, their purpose is 
more for assay development than for 
finding lead molecules.
After compound addition using 
the BioMek FX system, the cells were 
then grown for another two days, 
to reach full confluency within their 
wells. They were then read using the 
same method of Cell Titer-Glo and the 
Tecan Safire2 seen in the preliminary 
experiments. After reading the plates, 
the data was collected, and normalized 
so that the difference in growth could 
be easily seen. Again, the point was 
to find compounds that adversely 
affected the growth of the cancerous 
cell line, but caused no harm to 
the non-cancerous cell line. For a 
compound to be classified as “active”, 
there needed to be a difference of at 
least 50% in the growth of the two 
lines. The data was then analyzed to 
find the compounds that differed by at 
least 50% in growth, and the specific 
compounds noted.
The screen indicated 182 
compounds of interest that should 
be investigated further, as their 
effects differed  by more than 50%. 
Figure 6. This graph shows the overall effect of certain plates on the cell lines. A positive 
number means that the plate had an effect that caused toxicity in the cancerous cell line more 
than the normal cell line, and a negative number means that the normal cell line was more 
affected than the cancerous line. Plate A001 had a number of abnormalities that could have 
caused the plate to look as if was more toxic to the cancerous cell line than it actually was.
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Unfortunately, due to the time 
constraints of a student independent 
study, this work will have to be 
continued at a later date. The next step 
with these compounds is to confirm 
their activity, and ensure that they 
are not false positives / negatives. 
Unfortunately, many false positives 
/ negatives are expected during the 
checks, as there were pipetting errors 
with the robotic addition system 
used in the experiment. The next step 
includes performing the experiment 
again in the areas that were deemed 
problematic, and comparing those 
results against the original results 
to find false positives and negatives. 
Compounds that are confirmed as 
active should be used in dose-response 
experiments, to show the potency of 
the compounds. After dose-response 
curves have been calculated, the 
compounds should be used in other 
assays to determine the mechanism 
of action for the drugs. There are a 
number of assays to perform with the 
drugs, such as apoptosis assays, cell-
cycle arrest assays, and cytoskeletal 
assays. Once the mechanism of action 
is determined, the compounds can 
be used with toxicity mechanisms to 
develop new drug targets. Despite 
this being only the first, small step in 
fighting cancer, hopefully we can soon 
find a way to make these compounds 
deliverable to human beings, and 
eventually help those in need.
